REACH

Assessing the socio economic impacts under REACH

Together with our technical partners and sector-specific specialists we provide practical support to industry and public sector clients through the entire REACH authorisation and/or restriction process.

Our REACH services benefit from our extensive experience undertaking policy and investment appraisals, socio-economic analysis (SEA) and valuing impacts on companies, human health and the environment.

Regardless of the complexity of the work, we adhere to the principles of transparency and clarity when we:

  • Collect information, with clear audit trails and systems in place to protect the commercial confidentiality of data; and
  • Present information and analysis to ensure all is clear to target audiences with varying levels of technical knowledge

What is REACH?

Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) came into force on the 1st June 2007 across the European Union to replace a number of chemical-related European Directives and Regulations with a single system.  REACH applies to substances manufactured or imported into the EU in quantities of 1 tonne or more per year.  Generally, it applies to all individual chemical substances on their own, in preparations or in articles (if the substance is intended to be released during normal and reasonably foreseeable considerations of use from an article).

Links to further information:

Overview of REACH by the European Chemicals Agency (ECHA)

REACH briefing by the European Commission Environment Directorate General

REACH webpage by the UK Health and Safety Executive

Our REACH Services

Our toolkit of appraisal and evaluation methods includes:

  • Market assessments;
  • Stakeholder consultation;
  • Supply chain mapping;
  • Material flow analysis (MFA);
  • Value chains – which demonstrate the ‘value added’ along the supply chain;
  • Analysis of alternatives (AoA);
  • Valuation of economic impacts;
  • Valuation of social and macroeconomic impacts;
  • Valuation of human health and environmental risks; and
  • Cost Benefit Analysis (CBA).

In order to provide a complete REACH service, we work with consortium managers and technical specialists, such as ecotoxicologists and human health exposure experts.  Our REACH service includes:

  • REACH Advocacy
  • REACH Scoping Studies
  • REACH Socio Economic Analysis (SEA) Training
  • REACH Authorisation
  • REACH Restrictions
  • REACH Advocacy

    This involves assessing the benefits to society of continued use(s) of a substance (until a suitable alternative is available) compared to any possible risks, as well as, an assessment of possible alternatives. This can be done at use/sector level and enables sector associations, companies/consortia to communicate to regulators and other stakeholders their value to EU society before any regulatory decisions are made (i.e. a Risk Management Option Analysis - RMOA). Ideally this is prepared prior to or following a substance being included on ECHA’s Public Activities Coordination Tool (PACT).

    REACH – Scoping studies

    Preparing for authorisation (or responding to a possible restriction) involves significant effort, data, and time.  The scale of the work involved and quality of available data are often difficult to forecast from the outset. These can be “mini-applications” or are sometimes referred to as “setting out the business case”.

    This is based on readily available data to understand the position of the company/consortium (e.g. strengths and weaknesses of the business case) so that an informed decision can be made depending on the strength of the analysis.

    We work with partners to provide scoping studies that can range in focus and depth typically assessing the scale of the risks to human health and the environment, the benefits (value) of continued use the substance, and an initial screening of possible alternatives.  This can range from a 1-2 day workshop to a more in depth one month study.

    REACH – Socio Economic Analysis (SEA) training

    We deliver tailor-made half day or full day training workshops to develop an organisation’s understanding and ability to produce or respond to an SEA. The training helps companies understand (and prepare) the types of data they need and the key strategic decisions that need to be made.

    REACH – Authorisation

    We work with partners to assist companies and consortia with their applications for authorisation, including producing a Chemical Safety Report (CSR), Analysis of Alternatives (AoA) and SEA.

    Our REACH authorisation service provides:

    • Independent third party data collection to help gather data along the supply chain whilst preserving data confidentiality;
    • Organising and facilitating workshops to gather data along the supply chain in compliance with competition law;
    • Market analysis of a sector, product (end use), substance or supply chain;
    • Assessment and valuation of the benefits derived from use of the substance;
    • Assessment of the suitability (technical and economic feasibility) of alternatives;
    • Assessment and valuation of environmental and human health risks, and
    • Comparing the costs and benefits of changes in the use of a substance.

    REACH – Restrictions

    Restrictions limit or ban the manufacture and placing on the market or use of certain substances that pose an unacceptable risk to human health and the environment. We work with partners to support industry (and regulators) to help determine if restrictions are the most appropriate risk management option (RMO), and if a restriction is deemed necessary, which specific uses should be included and excluded (i.e. through a derogation).

    The restriction analysis is undertaken for each substance on a use-by-use basis and assesses whether the benefits of a particular type of restriction for a particular use outweighs any costs.

    Our REACH restrictions service provides:

    • Independent third party data collection to help gather data along the supply chain whilst preserving data confidentiality;
    • Organising and facilitating workshops to gather data along the supply chain in compliance with competition law;
    • Assessment of possible alternatives;
    • Market analysis of a sector, product (end use), substance or supply chain;
    • Assessment and valuation of the benefits derived the restriction;
    • Assessment and valuation of costs of a restriction;
    • Comparing the costs and benefits of a restriction against other RMOs to determine if restriction is the most appropriate Community wide action; and
    • Refining the scope of the proposed restriction (e.g. timescales, concentration limits and derogations).

    For specific examples of our REACH work in this area please visit our projects page and search for keyword ‘REACH’.



    10.jpg